Skip to main content

Table 5 Frequency of adverse effects

From: Lidocaine for systemic sclerosis: a double-blind randomized clinical trial

  

Group

 
  

Placebo

Lidocaine

P value

  

n

%

n

%

 

Frequency of adverse effects

No adverse effect

9

75,0%

6

50,0%

0,400 (F)

 

At least one effect

3

25,0%

6

50,0%

 
  1. (F): Fisher exact test